TSR-042 as Maintenance Therapy for Patients With High-risk Locally Advanced Cervical Cancer After Chemo-radiation (ATOMICC) (ATOMICC)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03833479 |
|
Recruitment Status :
Recruiting
First Posted : February 7, 2019
Last Update Posted : October 18, 2022
|
Sponsor:
Grupo Español de Investigación en Cáncer de Ovario
Collaborators:
TESARO/GSK
Apices Soluciones S.L.
Information provided by (Responsible Party):
Grupo Español de Investigación en Cáncer de Ovario
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | October 2025 |
| Estimated Study Completion Date : | October 2025 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):